Approved therapies for obesity and overweight include phentermine/topiramate, orlistat, naltrexone/bupropion, the glucagon-like peptide-1 receptor agonists liraglutide and semaglutide, tirzepatide, and bariatric surgery. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.